Registry News & Reports

Annual Cancer Incidence and Mortality Report
Marin County Breast Cancer Information
Recent Publications in the Scientific Literature
Reports on Special Topics

Annual Cancer Incidence and Mortality Report
This annual report presents information on all new cancer cases and deaths occurring in the Greater Bay Area from 1988 to the latest year for which information is available. For more information, please visit our Annual Report webpage.

Marin County Breast Cancer Information
The Greater Bay Area Cancer Registry closely monitors breast cancer rates in Marin County and the rest of the San Francisco Bay Area, where elevated rates have raised public concern. However, incidence rates for invasive breast cancer declined sharply for the years 2003 and 2004 both in the Bay Area and nationally. Work is ongoing to see if these declines are temporary and if they relate to the stoppage of hormone replacement therapy by many women after the July 2002 announcement by the Women's Health Initiative that estrogen/progestin hormone therapy increases the risk of developing breast cancer and heart disease. We are collaborating with the Marin County Health Department and their Marin Women's Study to better characterize patterns in hormone therapy use and breast cancer occurrence for Marin County since rates peaked there in 1999.

Please see the Annual Cancer Incidence and Mortality Report for the latest statistics on the rates of in situ and invasive breast cancer for Marin and other counties in the Bay Area. Scientific articles that may be of interest are listed below.

When possible, links to the full text or abstract are provided; some publications require a subscription or fee to access more than the abstract online.

Robbins AS, Clarke CA. A decline in breast-cancer incidence. N Engl J Med 2007 Aug 2;357(5):511-2; author reply 513.

Clarke CA, Glaser SL. Declines in breast cancer after the WHI: apparent impact of hormone therapy. Cancer Causes Control 2007 Oct;18(8):847-52. Epub 2007 Jul 6.

Robbins AS, Clarke CA. Regional changes in hormone therapy use and breast cancer incidence in California from 2001 to 2004. J Clin Oncol 2007 Aug 10;25(23):3437-9. Epub 2007 Jun 25.

Clarke CA, Glaser SL, Uratsu CS, Selby JV, Kushi LH, Herrinton LJ. Recent declines in hormone therapy utilization and breast cancer incidence: clinical and population-based evidence. J Clin Oncol 2006 Nov 20;49-50.

Clarke CA, Purdie DM, Glaser SL. Population attributable risk of breast cancer in white women associated with immediately modifiable risk factors. BMC Cancer 2006 Jun 27;6:170. (Full article in HTML)

Update on breast cancer incidence patterns in Marin County and the San Francisco Bay Area, California. Northern California Cancer Center, September 2004. (PDF)

Clarke C, Glaser S, West D, et al. Breast cancer incidence and mortality trends in an affluent population: Marin County, California, USA, 1990-1999. Breast Cancer Res 2002; 4:R13. (Full article in HTML).

Prehn A, Clarke C, Topol B, Glaser S, West D. Increase in breast cancer incidence in middle aged women during the 1990s. Ann Epidemiol 2002; 12:476-81.

Prehn AW, West DW. Evaluating local differences in breast cancer incidence rates: a census based methodology (United States). Cancer Causes Control 1998; 9:511-7.

Selected Recent Publications in the Scientific Literature
When possible, links to the full text or abstract are provided; some publications require a subscription or fee to access more than the abstract online.

Beckjord EB, Arora NK, McLaughlin W, Oakley-Girvan I, Hamilton AS, Hesse BW. Health-related information needs in a large and diverse sample of adult cancer survivors: Implications for cancer care. J Cancer Survivorship 2 (3):179-189, 2008.

Bloom JR, Stewart SL, Oakley-Girvan I, Banks PJ. Quality of life of young breast cancer survivors at 10 years. Published Abstract for presentation presented at International Psycho-Oncology Society, IPOS X, Madrid, Spain. Psycho-Oncology, 2008.

Borugian MJ, Spinelli JJ, Sun Z, Kolonel LN, Oakley-Girvan I, Pollak MD, Whittemore AS, Wh AH, Gallagher RP. Prostate cancer risk in relation to insulin-like growth factor (IGF)-I and IGF-binding protein-3: a prospective multiethnic study. Cancer Epidemiol Biomarkers Prev 17(1):252-254, 2008.

Carreon DJ, Morton LD, Devesa SS, Clarke CA, Gomez SL, Glaser SL, Sakoda LC, Linet MS, Wang SS. INcidence of lymphoid neoplasms by subtype among six Asian ethnic groups in the United States, 1996-2004. Cancer Causes Control 19(10):1171-1181, 2008.

Chan JK, Kapp DS, Shin JY, Osann K, Leiserowitz GS, Cress RD, O'Malley C. Factors associated with the suboptimal treatment of women less than 55 years of age with early-stage ovarian cancer in the California Teachers Study cohort. Nutr Cancer 60(3):285-291, 2008.

Chang ET, Lee VS, Canchola AJ, Dalvi T, Clarke CA, Reynolds P, Purdie DM, Stram DO, West DW, Ziogas A, Bernstein L, Horn-Ross PL. Dietary patterns and risk of ovarian cancer in the California Teachers Study cohort. Nutr Cancer 60(3):285-291, 2008

Chang ET, Milne RL, Phillips K, Figueiredo JC, Sangaramoorthy M, Keegan THM, Andrulis IL, Hopper JL, Goodwin PJ, O'Malley FP, Weerasooriya N, Apicella C, Southey MC, Friedlander ML, Giles GG, Whittemore As, West DW, John EM. Family history of breast cancer and all-cause mortality after breast cancer diagnosis in the Breast Cancer Family Registry. E-pub ahead of print. Breast Cancer Res Treat, 2008.

Chang ET, Clarke CA, Glaser SL. Making sense of seasonal fluctuations in lymphoma diagnosis. Leuk Lymph 2007;48(2):223-224.

Chang ET, Keegan THM, Gomez SL, Le GM, Clarke CA, So SK, Glaser SL. The burden of liver cancer in Asians and Pacific Islanders in the Greater San Francisco Bay Area, 1990 through 2004. Cancer 2007;109(10):2100-2108.

Clarke CA, Glaser SL. Declines in breast cancer after the WHI: apparent impact of hormone therapy. Cancer Causes Control 2007;18(8):847-852.

Clegg LX, Reichman ME, Hankey BF, Miller BA, Lin YD, Johnson NJ, Schwartz SM, Bernstein L, Chen VW, Goodman MT, Gomez SL, Graff JJ, Lynch CF, Lin CC, Edwards BK. Quality of race, Hispanic ethnicity, and immigrant status in population-based cancer registry data: implications for health disparity studies. Cancer Causes Control 2007;18(2):177-187.

Huang KP, Weinstock MA, Clarke CA, McMillan A, Hoppe, RT, Kim YH. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts. Archiv Dermatol 2007;143(1):45-50.

Keegan THM, Gomez SL, Clarke CA, Chan J, Glaser SL. Recent trends in breast cancer incidence among six Asian groups in the Greater Bay Area of Northern California. Int J Cancer 2007;120(6):1324-1349.

Morton LM, Turner JJ, Cerhan JR, Linet MS, Treseler PA, Clarke CA, Jack A, Cozen W, Maynadie M, Spinelli JJ, Costantini AS, Rudiger T, Scarpa A, Zheng T, Weisenburger DD. Proposed classification of lymphoid neoplasms for epidemiologic research from the International Lymphoma Epidemiology Consortium. Blood 2007;110(2):695-708.

Mueller NE, Grufferman S, Chang ET. Chapter 2: The Epidemiology of Hodgkin Lymphoma. In: Hoppe RT, Mauch PM, Armitage JO, Diehl V, Weiss LM (eds.) Hodgkin Lymphoma, 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins, pp. 7-23. 2007.

Robbins AS, Clarke CA. A decline in breast-cancer incidence (letter). N Engl J Med 2007;357(5):511-512.

Robbins AS, Clarke CA. Regional changes in hormone therapy use and breast cancer incidence, California, 2001-2004. J Clin Oncol 2007;25(23):3437-3439.

Robbins AS, Clarke CA. Response to Ravdin et al. (letter). New Engl J Med 2007;357(5):513.

Wakelee HA, Chang ET, Gomez SL, Keegan THM, Feskanich D, Clarke CA, Holmberg L, Yong LC, Kolonel LN, Gould MK, West DW. Lung cancer incidence in never-smokers. J Clin Oncol 2007;25(5):472-478.